Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Airiver Paclitaxel-Coated Pulmonary Balloon
- Development stage
- Unknown
- Lead developer
- Airiver Medical
- Modality
- Small Molecules, Device-based Delivery → Drug Delivery Systems
01
Overview
The Airiver Paclitaxel-Coated Pulmonary Balloon is an investigational drug-device combination developed by Airiver Medical for the treatment of benign central airway stenosis (BCAS). The device consists of a pulmonary balloon catheter coated with paclitaxel, a microtubule-stabilizing agent that functions as an antiproliferative drug. During bronchoscopic intervention, the balloon is inflated to mechanically dilate the stenotic airway, while the proprietary coating facilitates the localized delivery of paclitaxel to the airway wall. This targeted delivery is designed to inhibit the inflammatory and fibroproliferative processes that lead to tissue regrowth and restenosis, thereby maintaining airway patency longer than standard balloon dilation. The device has been evaluated in the OXYGEN-1 first-in-human trial and is progressing into a pivotal clinical trial under an FDA Investigational Device Exemption (IDE).
- Other names
- Airiver Pulmonary Drug Coated BalloonAiriver Pulmonary DCBPaclitaxel-Coated Pulmonary Balloon Catheter
02
Targets
TUBB (Tubulin (alpha and beta subunits))
Beyond the preview
Go deeper on Airiver Paclitaxel-Coated Pulmonary Balloon.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Airiver Paclitaxel-Coated Pulmonary Balloon.